Literature DB >> 24072099

Cytogenetics and outcome of infants with acute lymphoblastic leukemia and absence of MLL rearrangements.

P De Lorenzo1, A V Moorman2, R Pieters3, Z E Dreyer4, N A Heerema5, A J Carroll6, S P Hunger7, R Harvey8, C L Willman8, M Devidas9, M-G Valsecchi10, C J Harrison2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24072099      PMCID： PMC4285361          DOI： 10.1038/leu.2013.280

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  14 in total

Review 1.  Biological and therapeutic aspects of infant leukemia.

Authors:  A Biondi; G Cimino; R Pieters; C H Pui
Journal:  Blood       Date:  2000-07-01       Impact factor: 22.113

2.  High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9.

Authors:  Anne R M von Bergh; Ellen van Drunen; Elisabeth R van Wering; Laura J C M van Zutven; Ina Hainmann; Gudmar Lönnerholm; Jules P Meijerink; Rob Pieters; H Berna Beverloo
Journal:  Genes Chromosomes Cancer       Date:  2006-08       Impact factor: 5.006

3.  Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party.

Authors:  J M Chessells; C J Harrison; H Kempski; D K H Webb; K Wheatley; I M Hann; R F Stevens; G Harrison; B E Gibson
Journal:  Leukemia       Date:  2002-05       Impact factor: 11.528

4.  Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group.

Authors:  G H Reaman; R Sposto; M G Sensel; B J Lange; J H Feusner; N A Heerema; M Leonard; E J Holmes; H N Sather; T W Pendergrass; H S Johnstone; R T O'Brien; P G Steinherz; P M Zeltzer; P S Gaynon; M E Trigg; F M Uckun
Journal:  J Clin Oncol       Date:  1999-02       Impact factor: 44.544

5.  Therapeutic trial for infant acute lymphoblastic leukemia: the Pediatric Oncology Group experience (POG 8493).

Authors:  L S Frankel; J Ochs; J J Shuster; R Dubowy; W P Bowman; M Hockenberry-Eaton; M Borowitz; A J Carroll; C P Steuber; D J Pullen
Journal:  J Pediatr Hematol Oncol       Date:  1997 Jan-Feb       Impact factor: 1.289

6.  Abnormalities of chromosome bands 15q13-15 in childhood acute lymphoblastic leukemia.

Authors:  Nyla A Heerema; Harland N Sather; Martha G Sensel; Mei K L La; Raymond J Hutchinson; James B Nachman; Gregory H Reaman; Beverly J Lange; Peter G Steinherz; Bruce C Bostrom; Paul S Gaynon; Fatih M Uckun
Journal:  Cancer       Date:  2002-02-15       Impact factor: 6.860

7.  Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t(4;11) - a report of the Children's Cancer Group.

Authors:  N A Heerema; H N Sather; J Ge; D C Arthur; J M Hilden; M E Trigg; G H Reaman
Journal:  Leukemia       Date:  1999-05       Impact factor: 11.528

8.  Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987-1999.

Authors:  J M Chessells; C J Harrison; S L Watson; A J Vora; S M Richards
Journal:  Br J Haematol       Date:  2002-05       Impact factor: 6.998

9.  Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group.

Authors:  Joanne M Hilden; Patricia A Dinndorf; Sharon O Meerbaum; Harland Sather; Doojduen Villaluna; Nyla A Heerema; Ron McGlennen; Franklin O Smith; William G Woods; Wanda L Salzer; Helen S Johnstone; Zoann Dreyer; Gregory H Reaman
Journal:  Blood       Date:  2006-03-23       Impact factor: 22.113

10.  A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.

Authors:  Rob Pieters; Martin Schrappe; Paola De Lorenzo; Ian Hann; Giulio De Rossi; Maria Felice; Liisa Hovi; Thierry LeBlanc; Tomasz Szczepanski; Alice Ferster; Gritta Janka; Jeffrey Rubnitz; Lewis Silverman; Jan Stary; Myriam Campbell; Chi-Kong Li; Georg Mann; Ram Suppiah; Andrea Biondi; Ajay Vora; Maria Grazia Valsecchi
Journal:  Lancet       Date:  2007-07-21       Impact factor: 79.321
View more
  6 in total

1.  Clinical and molecular genetic characterization of wild-type MLL infant acute lymphoblastic leukemia identifies few recurrent abnormalities.

Authors:  Marieke H van der Linden; Judith M Boer; Pauline Schneider; Merel Willekes; Lidija Seslija; Paola De Lorenzo; Maria Grazia Valsecchi; Giovanni Cazzaniga; Andrea Biondi; Monique L den Boer; Rob Pieters; Ronald W Stam
Journal:  Haematologica       Date:  2015-12-17       Impact factor: 9.941

Review 2.  Acute Leukemia in Infants.

Authors:  Azada Ibrahimova; Lauren Pommert; Erin H Breese
Journal:  Curr Oncol Rep       Date:  2021-02-12       Impact factor: 5.075

3.  Cytogenetic Characteristics of Childhood Acute Lymphoblastic Leukemia: A Study of 1541 Chinese Patients Newly Diagnosed between 2001 and 2014.

Authors:  Meng-Meng Yin; Rui-Chi Wu; Jing Gao; Shao-Yan Hu; Xiao-Ming Liu; Xiao-Fan Zhu; Shu-Hong Shen; Jing-Yan Tang; Jing Chen; Qun Hu
Journal:  Curr Med Sci       Date:  2021-12-06

4.  The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias.

Authors:  Anna K Andersson; Jing Ma; Jianmin Wang; Xiang Chen; Amanda Larson Gedman; Jinjun Dang; Joy Nakitandwe; Linda Holmfeldt; Matthew Parker; John Easton; Robert Huether; Richard Kriwacki; Michael Rusch; Gang Wu; Yongjin Li; Heather Mulder; Susana Raimondi; Stanley Pounds; Guolian Kang; Lei Shi; Jared Becksfort; Pankaj Gupta; Debbie Payne-Turner; Bhavin Vadodaria; Kristy Boggs; Donald Yergeau; Jayanthi Manne; Guangchun Song; Michael Edmonson; Panduka Nagahawatte; Lei Wei; Cheng Cheng; Deqing Pei; Rosemary Sutton; Nicola C Venn; Albert Chetcuti; Amanda Rush; Daniel Catchpoole; Jesper Heldrup; Thoas Fioretos; Charles Lu; Li Ding; Ching-Hon Pui; Sheila Shurtleff; Charles G Mullighan; Elaine R Mardis; Richard K Wilson; Tanja A Gruber; Jinghui Zhang; James R Downing
Journal:  Nat Genet       Date:  2015-03-02       Impact factor: 38.330

5.  Outstanding outcomes in infants with KMT2A-germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children's Oncology Group AALL0631 trial.

Authors:  Erin M Guest; John A Kairalla; Joanne M Hilden; ZoAnn E Dreyer; Andrew J Carroll; Nyla A Heerema; Cindy Y Wang; Meenakshi Devidas; Lia Gore; Wanda L Salzer; Naomi J Winick; William L Carroll; Elizabeth A Raetz; Michael Borowitz; Mignon L Loh; Stephen P Hunger; Patrick A Brown
Journal:  Haematologica       Date:  2022-05-01       Impact factor: 9.941

Review 6.  MLL-Rearranged Acute Leukemia with t(4;11)(q21;q23)-Current Treatment Options. Is There a Role for CAR-T Cell Therapy?

Authors:  Oliver Britten; Denise Ragusa; Sabrina Tosi; Yasser Mostafa Kamel
Journal:  Cells       Date:  2019-10-29       Impact factor: 6.600
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.